Volume 30, Issue 3, Pages (March 2009)

Slides:



Advertisements
Similar presentations
Volume 40, Issue 4, Pages (April 2014)
Advertisements

Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Volume 5, Issue 1, Pages (January 2009)
Volume 31, Issue 2, Pages (August 2009)
Volume 45, Issue 1, Pages (July 2016)
Volume 6, Issue 2, Pages (August 2009)
David Voehringer, Kanade Shinkai, Richard M Locksley  Immunity 
Volume 36, Issue 5, Pages (May 2012)
Volume 43, Issue 2, Pages (August 2015)
Volume 25, Issue 4, Pages (October 2006)
Volume 18, Issue 5, Pages (May 2003)
Volume 32, Issue 5, Pages (May 2010)
Volume 37, Issue 1, Pages (July 2012)
Lung Airway-Surveilling CXCR3hi Memory CD8+ T Cells Are Critical for Protection against Influenza A Virus  Bram Slütter, Lecia L. Pewe, Susan M. Kaech,
Volume 40, Issue 3, Pages (March 2014)
Volume 35, Issue 6, Pages (December 2011)
Volume 21, Issue 7, Pages (November 2017)
Cytotoxic CD8+ T Cells Stimulate Hematopoietic Progenitors by Promoting Cytokine Release from Bone Marrow Mesenchymal Stromal Cells  Christian M. Schürch,
Volume 29, Issue 2, Pages (August 2008)
Volume 29, Issue 2, Pages (August 2008)
Volume 42, Issue 4, Pages (April 2015)
Volume 36, Issue 5, Pages (May 2012)
Volume 25, Issue 3, Pages (September 2006)
Protective Capacity of Memory CD8+ T Cells Is Dictated by Antigen Exposure History and Nature of the Infection  Jeffrey C. Nolz, John T. Harty  Immunity 
Volume 40, Issue 4, Pages (April 2014)
Volume 33, Issue 1, Pages (July 2010)
Volume 45, Issue 1, Pages (July 2016)
Volume 44, Issue 3, Pages (March 2016)
Volume 34, Issue 4, Pages (April 2011)
Volume 44, Issue 1, Pages (January 2016)
Novel Role of the Ras Cascade in Memory B Cell Response
Volume 29, Issue 6, Pages (December 2008)
Volume 27, Issue 3, Pages (September 2007)
Volume 6, Issue 6, Pages (December 2009)
Volume 33, Issue 4, Pages (October 2010)
Natural IgE Production in the Absence of MHC Class II Cognate Help
Blimp-1 Transcription Factor Is Required for the Differentiation of Effector CD8+ T Cells and Memory Responses  Axel Kallies, Annie Xin, Gabrielle T.
Volume 45, Issue 4, Pages (October 2016)
Volume 32, Issue 5, Pages (May 2010)
Volume 5, Issue 1, Pages (January 2009)
An Interleukin-21- Interleukin-10-STAT3 Pathway Is Critical for Functional Maturation of Memory CD8+ T Cells  Weiguo Cui, Ying Liu, Jason S. Weinstein,
Volume 35, Issue 2, Pages (August 2011)
Volume 39, Issue 2, Pages (August 2013)
B Cell Multitasking Is Required to Control Nematode Infection
Volume 4, Issue 4, Pages (October 2008)
Volume 29, Issue 1, Pages (July 2008)
Volume 43, Issue 5, Pages (November 2015)
Volume 34, Issue 6, Pages (June 2011)
Volume 29, Issue 5, Pages (November 2008)
CTLA-4 Regulates Induction of Anergy In Vivo
Volume 41, Issue 1, Pages (July 2014)
Volume 31, Issue 4, Pages (October 2009)
Volume 38, Issue 3, Pages (March 2013)
Cell-Intrinsic IL-27 and gp130 Cytokine Receptor Signaling Regulates Virus-Specific CD4+ T Cell Responses and Viral Control during Chronic Infection 
Volume 35, Issue 1, Pages (July 2011)
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
CD44 Regulates Survival and Memory Development in Th1 Cells
Volume 16, Issue 1, Pages (July 2014)
Volume 34, Issue 3, Pages (March 2011)
Antigen-Specific Suppression of a Primed Immune Response by Dendritic Cells Mediated by Regulatory T Cells Secreting Interleukin-10  Ela Martin, Brendan.
David Voehringer, Kanade Shinkai, Richard M Locksley  Immunity 
Volume 40, Issue 5, Pages (May 2014)
Volume 28, Issue 5, Pages (May 2008)
Volume 36, Issue 5, Pages (May 2012)
Notch 1 Signaling Regulates Peripheral T Cell Activation
Volume 30, Issue 5, Pages (May 2009)
Volume 31, Issue 6, Pages (December 2009)
Volume 32, Issue 5, Pages (May 2010)
B1b Lymphocytes Confer T Cell-Independent Long-Lasting Immunity
Volume 10, Issue 3, Pages (March 1999)
Presentation transcript:

Volume 30, Issue 3, Pages 421-433 (March 2009) Cytokine-Producing Effector B Cells Regulate Type 2 Immunity to H. polygyrus  Wojciech Wojciechowski, David P. Harris, Frank Sprague, Betty Mousseau, Melissa Makris, Kim Kusser, Tasuko Honjo, Katja Mohrs, Markus Mohrs, Troy Randall, Frances E. Lund  Immunity  Volume 30, Issue 3, Pages 421-433 (March 2009) DOI: 10.1016/j.immuni.2009.01.006 Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 1 B Cells Are Required for Protective Immunity to Hp (A and B) C57BL/6 and μMT mice (A) or BALB/c and JHD mice (B) were exposed to two rounds of L3 Hp infection and drug treatment with pyrantel pamoate. The memory mice (secondary) and a group of naive mice (primary) were then challenged with L3 Hp, and parasite burdens were determined on day 20. (C) C57BL/6 and μMT mice were infected with L3 Hp, and the number of adult parasites in the intestine was determined on days 6, 7, 8, 9, 10, and 21 after infection. The data are shown as mean ± SD (n = 3–4 mice per group per time point). (D) C57BL/6 and μMT mice were infected with L3 Hp or were sham infected. Three weeks later, all mice were treated with pyrantel pamoate. Ten days after the last drug treatment, all mice were infected with L3 Hp. The number of adult parasites present in the intestinal lumen of the previously infected mice (secondary) and previously naive mice (primary) was determined at the times indicated. The data are shown as mean ± SD (n = 3–4 mice per group per time point). The results shown are representative of two or more independent experiments. Immunity 2009 30, 421-433DOI: (10.1016/j.immuni.2009.01.006) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 2 Isotype-Switched Ab Is Necessary But Not Sufficient for Protection from Hp Challenge C57BL/6, μMT, μs, or μs–Aicda−/− mice were exposed to two rounds of infection with L3 Hp and drug treatment with pyrantel pamoate. (A–C) Mice were challenged with L3 Hp and the (A) number of CD19+PNAhiFAS+ germinal center B cells in the mLNs was determined 13 days later by flow cytometry. Titers of (B) Hp-specific IgM and (C) Hp-specific IgG1 were determined by ELISA. (D) The number of adult parasites present in the intestinal lumen was determined. (E) C57BL/6 and μMT mice were exposed to two rounds of Hp infection and drug treatment. 200 μl of Hp immune serum (IS) or normal mouse serum (NMS) was injected (i.p.) into the memory μMT and B6 recipients two days before, the day of, and two days after a challenge infection with Hp. Parasite burdens were determined 19 days later. Data are represented as the mean ± SD (n = 10 mice per group). Data are representative of two individual experiments. Immunity 2009 30, 421-433DOI: (10.1016/j.immuni.2009.01.006) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 3 B cells Regulate Hp-Specific Th2 Cell Commitment, Expansion, and Differentiation B cell-deficient μMT mice were lethally irradiated and reconstituted with 4get BM (4get chimeras) or with B cell-deficient 4get BM (4getμMT chimeras). (A) The chimeric mice were infected with Hp, and the number of EGFP+CD62LloCD4+ T cells in the mLNs was determined by flow cytometry at various times. (B) Cells from the mLNs were stimulated with plate-bound anti-CD3 for 4 hr in the presence of Brefeldin A, and the numbers of IL-4+EGFP+ CD4+ T cells were determined with flow cytometry. Data are shown as the mean ± SD of 4–5 mice per group per time point. “∗”: Statistically significant differences (p ≤ 0.02) between the 4get and 4getμMT groups were found at each of the indicated time points. “#”: Statistically significant differences (p ≤ 0.05) between day 0 4getμMT mice and day 8 4getμMT mice are indicated. (C) C57BL/6 and μMT mice were infected with L3 Hp, and CD4+ cells were purified from pooled mLNs 21 days later. Purified CD4+ T cells were restimulated with Hp antigen-pulsed APCs, and cytokine levels in the supernatants were determined by cytometric bead array. The results shown are representative of three independent experiments. Immunity 2009 30, 421-433DOI: (10.1016/j.immuni.2009.01.006) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 4 Th2 Memory Cell Responses to Hp Are Dependent on B Cells B cell-deficient μMT mice were irradiated and reconstituted with BM from either 4get mice (4get chimeras) or B cell-deficient 4get mice (4getμMT chimeras). Chimeric mice were infected with Hp and drug treated on day 21. On day 60, a cohort of mice was analyzed (memory time point), and the remainder of the mice were challenged with L3 Hp. Mesenteric cells were analyzed for expression of CD4, EGFP, and CD62L by flow cytometry. (A and B) Plots gated on live CD4+ T cells and are representative of mice at (A) the memory time point and (B) 5 days after challenge. The numbers in each quadrant indicate the percentage of CD4+ T cells that express EGFP or CD62L. (C) The number of EGFP+CD62loCD4+ T cells present in the mLNs at the memory time point and various times after challenge was determined. (D and E) Cells from mLNs of (D) memory and (E) day 5 postchallenge mice were restimulated with plate-bound anti-CD3 in the presence of Brefeldin A for 4 hr, and the expression of IL-4 and EGFP on the CD4+ T cells was determined by flow cytometry. The percentage of EGFP+CD4+ cells coexpressing IL-4 is indicated in the plot (mean ± SD of 5 mice per group). (F) The number of EGFP+IL-4+CD4+ T cells present in the mLNs at the memory time point and various times after challenge was determined. Data in (C) and (F) are shown as the mean ± SD of 4–5 mice per group. “∗”: Statistically significant differences (p ≤ 0.002) between the 4get and 4getμMT groups were found at each of the indicated time points. “#”: Statistically significant differences (p ≤ 0.03) between day 0 4getμMT mice and day 3 4getμMT mice are indicated. (G) C57BL/6 and μMT mice were infected with Hp, drug treated, then challenged with 200 L3 Hp. Ten days later, CD4+ T cells were purified from pooled mLNs and restimulated with Hp antigen-pulsed APCs overnight. Cytokines in the supernatants were quantified by cytometric bead array. The results shown are representative of three independent experiments. Immunity 2009 30, 421-433DOI: (10.1016/j.immuni.2009.01.006) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 5 Th2 Cell-Mediated Immunity to Hp Is Dependent on Antigen-Presenting, Antigen-Specific B Cells But Does Not Require Ab-Producing B Cells (A) Irradiated μMT mice were reconstituted with 75% 4getμMT BM and 25% μMT BM (μMT chimeras), with 75% 4getμMT BM and 25% C57BL/6 BM (B-WT chimeras) or with 75% 4getμMT BM and 25% μs_Aicda−/− BM (B-μs_Aicda−/− chimeras). The chimeric mice were infected with Hp, drug treated, then challenged with 200 L3 Hp. EGFP+CD62LloCD4+ T cells in the mLNs were enumerated by flow cytometry 6 days after challenge. (B–D) Irradiated μMT mice were reconstituted with 100% μMT BM (μMT chimeras), with 75% μMT BM and 25% C57BL/6 BM (B-WT chimeras) or with 75% μMT BM and 25% class II-deficient BM (B-MHCII-deficient chimeras). The reconstituted mice were exposed to two rounds of Hp infection and drug treatment and were then challenged with 200 L3 Hp. (B) Parasite burdens were determined for individual animals on day 21 and (C) serum titers of Hp-specific IgG1 were determined by ELISA. (D) CD4+ T cells were purified from pooled mLNs and stimulated with plate-bound anti-CD3 overnight. IL-4 levels in the T cell supernatants were determined by ELISA. (E and F) B6 mice and MD4 μMT mice were exposed to two rounds of Hp infection and drug treatment and were then challenged with L3 Hp. (E) Parasite burdens were determined for individual animals. (F) Cells from the mLNs of each group were pooled, and the CD4+ T cells were purified and stimulated on anti-CD3-coated plates. Cytokine levels in the culture supernatants were determined by cytokine bead array at 24 hr after restimulation. The data are shown as the mean ± SD of 4–5 mice per group. The results shown are representative of two or more independent experiments. Immunity 2009 30, 421-433DOI: (10.1016/j.immuni.2009.01.006) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 6 IL-4Rα Expression on B Cells Is Required for the In Vivo Development of Be-2 Cells and for Immunity to Hp B cell-deficient JHD mice were irradiated and reconstituted with 80% JHD BM and 20% 4get BM (B-4get) or with 80% JHD BM and 20% 4get-Il4ra−/− BM (B-4get-Il4ra−/−). Reconstituted mice were exposed to two rounds of L3 Hp infection and drug treatment and then challenged with 200 L3 Hp. (A) The number of live (PIneg), EGFP-expressing CD19+CD4neg B cells in the mLNs was determined by flow cytometry. EGFP+ B cells present in the mLNs of uninfected 4get or 4get-Il4ra−/− mice represent ≤ 0.01% of the total B cell pool or 100–300 B cells per mLN (Harris et al., 2005b). (B) Titers of Hp-specific IgG1 in serum were determined by ELISA. (C) Adult parasites were enumerated by counting. The results shown are representative of two independent experiments. Immunity 2009 30, 421-433DOI: (10.1016/j.immuni.2009.01.006) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 7 Protective Humoral and Cellular Immune Responses to Hp Are Controlled by Cytokine-Producing Effector B Cells (A) Irradiated μMT mice were reconstituted with 100% μMT BM (μMT chimeras), with 75% μMT BM and 25% C57BL/6 BM (B-WT chimeras) or with 75% μMT BM and 25% Il4−/− BM (B-Il4−/− chimeras). The reconstituted mice were exposed to two rounds of L3 Hp infection and drug treatment and were then challenged with L3 Hp. Parasite burden was determined on day 21. (B, D, F) Irradiated μMT mice were reconstituted with 75% μMT BM and 25% Il2−/− BM (B-Il2−/− chimeras), with 100% Il2−/− BM (Il2−/− chimeras), with 100% μMT BM (μMT chimeras), or with 75% μMT BM and 25% C57BL/6 BM (B-WT chimeras). (C, E, G) Irradiated μMT mice were reconstituted with 75% μMT BM and 25% Tnf−/− BM (B-Tnf−/− chimeras), with 100% Tnf−/− BM (Tnf−/− chimeras), with 100% μMT BM (μMT chimeras), or with 75% μMT BM and 25% C57BL/6 BM (B-WT chimeras). In separate experiments, the cytokine chimeras along with control B-WT and μMT chimeras were infected and drug-treated twice and then challenged with L3 Hp. Parasite burden in the lumen was determined on (B) day 12 or (C) day 10 after infection. (D and E) Cells from mLNs of cytokine chimeras and controls were stimulated in the presence of Brefeldin A for 5 hr on anti-CD3-coated plates, and the number of IL-4-producing CD4+ T cells was determined by flow cytometry. (F and G) Serum titers of Hp-specific IgG1 were determined by ELISA. All data are shown as the mean ± SD of ≥ 5 mice per group. The results shown are representative of two or more independent experiments. Immunity 2009 30, 421-433DOI: (10.1016/j.immuni.2009.01.006) Copyright © 2009 Elsevier Inc. Terms and Conditions